Home / Meetings & Education / ISHLTv: Online Learning / Industry Webinars / Recorded Webinars

Recorded Webinars

DATE

BY DATE

2023

Modernizing Your Transplant Program with an Integrated EVLP Service

1 June, 2023

Join ISHLT and Lung Bioengineering (LBE) for a one-hour webinar where an experienced LBE partner transplant center will provide a first-hand account of how their program has grown through utilization of EVLP services.

Matthew Bacchetta, MD will discuss how partnering with LBE for EVLP services has influenced the practices and mindset of the Vanderbilt University Medical Center lung transplant program over time. This program will be of interest to any clinician at a lung transplant center.

2022

	Review of the HVAD Landscape Since June 2021 13 December, 2022 More than a year has passed since Medtronic announced their decision to stop the distribution and sale of the HeartWare™ HVAD™ System. Our distinguished faculty will discuss the current HVAD landscape to include an update on HVAD patient management, best practices, and the UNOS policy change. FACULTY: Lori Schaefer \| USA Diyar Saeed, MD, PhD \| Germany Mark Slaughter, MD \| Kentucky, USA Chris Hayward, MD \| Australia Song Li, MD \| Washington, USA Shelley Hall, MD \| Texas, USA Pieter Kappetein, MD, PhD \| The Netherlands

	Immunosuppressant Sparing in Solid Organ Transplantation 9 November, 2022 Doctor James Hutchinson Doctor James Hutchinson is a Professor of Transplant Immunology at University Hospital Regensburg in Germany. His research interests revolve around tolerance induction, cell-based immunotherapy and monitoring immune responses in patients to guide treatment decisions. This webinar is not intended for healthcare professionals based in the US and Canada.

2021

	ECP as an Immunosuppressant-sparing Approach in Lung Transplant Patients 30 November, 2021 Professor Christian Benden Adjunct Professor of Pneumology and Transplant Medicine at the University of Zurich, Switzerland. He is the former Medical Director of Lung Transplantation and Chairman of the Board of Trustees of the Transplant Center of the University Hospital Zurich. He is an Associate Editor of Clinical Transplantation and Editorial Board Member of the Journal of Heart and Lung Transplantation. He is currently Secretary of the Board of Directors and Executive Committee Member of the International Society for Heart and Lung Transplantation (ISHLT), and ISHLT Past Scientific Program Chair.

	Role and Impact of ECP in the Treatment of CLAD Patients 19 October, 2021 Doctor Mark Greer Transplant pulmonologist at Hannover Medical School with over 10 years of experience in evaluating and managing lung transplant recipients. He has published extensively on various aspects of lung transplantation, including the role of extracorporeal photopheresis.

	Redefining the Limits: Surgical and Medical Considerations for Using the HeartMate 3™ LVAD in Small Patients 20 September, 2021 During this webinar, a panel of expert physicians will discuss surgical and medical considerations for small-sized patients with advanced heart failure. The discussion will include patient candidacy, surgical techniques, and patient management strategies utilizing the HeartMate 3™ LVAD. Presenters: Dr. Jennifer Cowger, Henry Ford Health System Dr. Tomoyuki Fujita, National Cerebral and Cardiovascular Center Dr. Angela Lorts, Cincinnati Children's Hospital Medical Center Dr. Ezequiel J Molina, Georgetown University, MedStar Heart & Vascular Institute Dr. Nir Uriel, New-York Presbyterian, Columbia University Medical Center

2020

	Advanced Heart Preservation for 2021: Paragonix SherpaPak CTS 17 December, 2020 The Paragonix Team assembled a panel of industry-leading experts to host this seminal discussion on current and future preservation techniques for heart transplantation in both adults and children. Relying on over a century of transplant experience, the panel investigates the importance of well-controlled preservation systems for organ transportation in improved patient outcomes. Presenters: Dr. Yasuhiro Shudo, Stanford University \| Pioneering Advanced Preservation on the West Coast Dr. Rajamiyer Venkateswaran, Wythenshawe Hospital \| ISHLT Consensus Statement and UK National SherpaPak Program Dr. Ulrich Stock, Harefield Hospital \| Introduction of Advanced Hypothermic Preservation Dr. Jeffrey Jacobs, University of Florida

	VAD Therapy Trends: Why Meaningful Data Matters 13 December, 2020 Hear key opinion leaders from around the world share their experiences in mechanical circulatory support. Watch this lively discussion, as the presenters explore data and trends in surgical approach, right heart failure, and patient management to achieve excellent outcomes for patients implanted with the HVAD™ System. Moderator: Dr. Mark Slaughter, Jewish Hospital and St. Mary's Healthcare System Presenters: Dr. Anson Cheung, University of British Columbia and St. Paul's Hospital Dr. Erika Feller, University of Maryland Medical Center Prof. Dr. med. Evgenij V. Potapov, Deutsches Herzzentrum Berlin Dr. Christopher T. Salerno, St. Vincent Hospital Indianapolis Dr. Stephan Schueler, Freeman Hospital

	HeartCare Multi-Modality Testing for Heart Transplant Patients 11 November, 2020 Presenters: Dr. Kiran Khush, Stanford University \| Donor-Derived Cell-Free DNA and Gene Expression Profiling: A Combined Approach to Heart Transplantation Surveillance Dr. Eugene DePasquale, University of Southern California \| Review of Patient Case Studies and the Role of HeartCare

	HeartMate 3 LVAD™ Clinical Data Presentations - ISHLT 2020 Annual Meeting 21 October, 2020 This video is a collection of mini-oral presentations by leading thought leaders discussing their research in patients who received the HeartMate 3 LVAD. These studies were highlighted at The International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting in 2020. Abbott has a deep commitment to well-designed clinical research and outcomes, and these presentations will inform the future of patient care. Presenters: Dr. Robert L. Kormos, Abbott \| Facilitator Dr. Omar Saeed, Montefiore-Einstein Medical Center \| Effect of Aspirin Dose on Hemocompatibility Related Outcomes with a Magnetically Levitated Left Ventricular Assist Device: An Analysis from the MOMENTUM 3 Study Dr. Manreet K. Kanwar, Allegheny General Hospital \| Impact of Left Ventricular Assist Device Implantation on Mitral Regurgitation: An Analysis from the MOMENTUM 3 Trial Dr. Jonathan W. Haft, University of Michigan \| The Impact of Heartmate 3 Speed on Outcomes in the Momentum 3 Clinical Trial Dr. Jennifer Cowger, Henry Ford Hospital \| Variability in Blood Pressure Assessment in Patients Supported with the HeartMate 3 Dr. Ivan Netuka, Institute of Clinical and Experimental Medicine \| First Long-Term 5-years Experience with the HeartMate 3 LVAS in Multicentric Clinical Trial

HEART

	Immunosuppressant Sparing in Solid Organ Transplantation 9 November, 2022 Doctor James Hutchinson Doctor James Hutchinson is a Professor of Transplant Immunology at University Hospital Regensburg in Germany. His research interests revolve around tolerance induction, cell-based immunotherapy and monitoring immune responses in patients to guide treatment decisions. This webinar is not intended for healthcare professionals based in the US and Canada.

	Advanced Heart Preservation for 2021: Paragonix SherpaPak CTS 17 December, 2020 The Paragonix Team assembled a panel of industry-leading experts to host this seminal discussion on current and future preservation techniques for heart transplantation in both adults and children. Relying on over a century of transplant experience, the panel investigates the importance of well-controlled preservation systems for organ transportation in improved patient outcomes. Presenters: Dr. Yasuhiro Shudo, Stanford University \| Pioneering Advanced Preservation on the West Coast Dr. Rajamiyer Venkateswaran, Wythenshawe Hospital \| ISHLT Consensus Statement and UK National SherpaPak Program Dr. Ulrich Stock, Harefield Hospital \| Introduction of Advanced Hypothermic Preservation Dr. Jeffrey Jacobs, University of Florida

	HeartCare Multi-Modality Testing for Heart Transplant Patients 11 November, 2020 Presenters: Dr. Kiran Khush, Stanford University \| Donor-Derived Cell-Free DNA and Gene Expression Profiling: A Combined Approach to Heart Transplantation Surveillance Dr. Eugene DePasquale, University of Southern California \| Review of Patient Case Studies and the Role of HeartCare

LUNG

	Modernizing Your Transplant Program with an Integrated EVLP Service 1 June, 2023 Join ISHLT and Lung Bioengineering (LBE) for a one-hour webinar where an experienced LBE partner transplant center will provide a first-hand account of how their program has grown through utilization of EVLP services. Matthew Bacchetta, MD will discuss how partnering with LBE for EVLP services has influenced the practices and mindset of the Vanderbilt University Medical Center lung transplant program over time. This program will be of interest to any clinician at a lung transplant center.

	Immunosuppressant Sparing in Solid Organ Transplantation 9 November, 2022 Doctor James Hutchinson Doctor James Hutchinson is a Professor of Transplant Immunology at University Hospital Regensburg in Germany. His research interests revolve around tolerance induction, cell-based immunotherapy and monitoring immune responses in patients to guide treatment decisions. This webinar is not intended for healthcare professionals based in the US and Canada.

	ECP as an Immunosuppressant-sparing Approach in Lung Transplant Patients 30 November, 2021 Professor Christian Benden Adjunct Professor of Pneumology and Transplant Medicine at the University of Zurich, Switzerland. He is the former Medical Director of Lung Transplantation and Chairman of the Board of Trustees of the Transplant Center of the University Hospital Zurich. He is an Associate Editor of Clinical Transplantation and Editorial Board Member of the Journal of Heart and Lung Transplantation. He is currently Secretary of the Board of Directors and Executive Committee Member of the International Society for Heart and Lung Transplantation (ISHLT), and ISHLT Past Scientific Program Chair.

	Role and Impact of ECP in the Treatment of CLAD Patients 19 October, 2021 Doctor Mark Greer Transplant pulmonologist at Hannover Medical School with over 10 years of experience in evaluating and managing lung transplant recipients. He has published extensively on various aspects of lung transplantation, including the role of extracorporeal photopheresis.

MCS

	Review of the HVAD Landscape Since June 2021 13 December, 2022 More than a year has passed since Medtronic announced their decision to stop the distribution and sale of the HeartWare™ HVAD™ System. Our distinguished faculty will discuss the current HVAD landscape to include an update on HVAD patient management, best practices, and the UNOS policy change. FACULTY: Lori Schaefer \| USA Diyar Saeed, MD, PhD \| Germany Mark Slaughter, MD \| Kentucky, USA Chris Hayward, MD \| Australia Song Li, MD \| Washington, USA Shelley Hall, MD \| Texas, USA Pieter Kappetein, MD, PhD \| The Netherlands

	Redefining the Limits: Surgical and Medical Considerations for Using the HeartMate 3™ LVAD in Small Patients 20 September, 2021 During this webinar, a panel of expert physicians will discuss surgical and medical considerations for small-sized patients with advanced heart failure. The discussion will include patient candidacy, surgical techniques, and patient management strategies utilizing the HeartMate 3™ LVAD. Presenters: Dr. Jennifer Cowger, Henry Ford Health System Dr. Tomoyuki Fujita, National Cerebral and Cardiovascular Center Dr. Angela Lorts, Cincinnati Children's Hospital Medical Center Dr. Ezequiel J Molina, Georgetown University, MedStar Heart & Vascular Institute Dr. Nir Uriel, New-York Presbyterian, Columbia University Medical Center

	VAD Therapy Trends: Why Meaningful Data Matters 13 December, 2020 Hear key opinion leaders from around the world share their experiences in mechanical circulatory support. Watch this lively discussion, as the presenters explore data and trends in surgical approach, right heart failure, and patient management to achieve excellent outcomes for patients implanted with the HVAD™ System. Moderator: Dr. Mark Slaughter, Jewish Hospital and St. Mary's Healthcare System Presenters: Dr. Anson Cheung, University of British Columbia and St. Paul's Hospital Dr. Erika Feller, University of Maryland Medical Center Prof. Dr. med. Evgenij V. Potapov, Deutsches Herzzentrum Berlin Dr. Christopher T. Salerno, St. Vincent Hospital Indianapolis Dr. Stephan Schueler, Freeman Hospital

	HeartMate 3 LVAD™ Clinical Data Presentations - ISHLT 2020 Annual Meeting 21 October, 2020 This video is a collection of mini-oral presentations by leading thought leaders discussing their research in patients who received the HeartMate 3 LVAD. These studies were highlighted at The International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting in 2020. Abbott has a deep commitment to well-designed clinical research and outcomes, and these presentations will inform the future of patient care. Presenters: Dr. Robert L. Kormos, Abbott \| Facilitator Dr. Omar Saeed, Montefiore-Einstein Medical Center \| Effect of Aspirin Dose on Hemocompatibility Related Outcomes with a Magnetically Levitated Left Ventricular Assist Device: An Analysis from the MOMENTUM 3 Study Dr. Manreet K. Kanwar, Allegheny General Hospital \| Impact of Left Ventricular Assist Device Implantation on Mitral Regurgitation: An Analysis from the MOMENTUM 3 Trial Dr. Jonathan W. Haft, University of Michigan \| The Impact of Heartmate 3 Speed on Outcomes in the Momentum 3 Clinical Trial Dr. Jennifer Cowger, Henry Ford Hospital \| Variability in Blood Pressure Assessment in Patients Supported with the HeartMate 3 Dr. Ivan Netuka, Institute of Clinical and Experimental Medicine \| First Long-Term 5-years Experience with the HeartMate 3 LVAS in Multicentric Clinical Trial

PVD

There are currently no ISHLTv Industry Webinars available that are relevant to PVD.

	Advanced Heart Preservation for 2021: Paragonix SherpaPak CTS 17 December, 2020 The Paragonix Team assembled a panel of industry-leading experts to host this seminal discussion on current and future preservation techniques for heart transplantation in both adults and children. Relying on over a century of transplant experience, the panel investigates the importance of well-controlled preservation systems for organ transportation in improved patient outcomes. Presenters: Dr. Yasuhiro Shudo, Stanford University \| Pioneering Advanced Preservation on the West Coast Dr. Rajamiyer Venkateswaran, Wythenshawe Hospital \| ISHLT Consensus Statement and UK National SherpaPak Program Dr. Ulrich Stock, Harefield Hospital \| Introduction of Advanced Hypothermic Preservation Dr. Jeffrey Jacobs, University of Florida

	VAD Therapy Trends: Why Meaningful Data Matters 13 December, 2020 Hear key opinion leaders from around the world share their experiences in mechanical circulatory support. Watch this lively discussion, as the presenters explore data and trends in surgical approach, right heart failure, and patient management to achieve excellent outcomes for patients implanted with the HVAD™ System. Moderator: Dr. Mark Slaughter, Jewish Hospital and St. Mary's Healthcare System Presenters: Dr. Anson Cheung, University of British Columbia and St. Paul's Hospital Dr. Erika Feller, University of Maryland Medical Center Prof. Dr. med. Evgenij V. Potapov, Deutsches Herzzentrum Berlin Dr. Christopher T. Salerno, St. Vincent Hospital Indianapolis Dr. Stephan Schueler, Freeman Hospital

	HeartCare Multi-Modality Testing for Heart Transplant Patients 11 November, 2020 Presenters: Dr. Kiran Khush, Stanford University \| Donor-Derived Cell-Free DNA and Gene Expression Profiling: A Combined Approach to Heart Transplantation Surveillance Dr. Eugene DePasquale, University of Southern California \| Review of Patient Case Studies and the Role of HeartCare

	HeartMate 3 LVAD™ Clinical Data Presentations - ISHLT 2020 Annual Meeting 21 October, 2020 This video is a collection of mini-oral presentations by leading thought leaders discussing their research in patients who received the HeartMate 3 LVAD. These studies were highlighted at The International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting in 2020. Abbott has a deep commitment to well-designed clinical research and outcomes, and these presentations will inform the future of patient care. Presenters: Dr. Robert L. Kormos, Abbott \| Facilitator Dr. Omar Saeed, Montefiore-Einstein Medical Center \| Effect of Aspirin Dose on Hemocompatibility Related Outcomes with a Magnetically Levitated Left Ventricular Assist Device: An Analysis from the MOMENTUM 3 Study Dr. Manreet K. Kanwar, Allegheny General Hospital \| Impact of Left Ventricular Assist Device Implantation on Mitral Regurgitation: An Analysis from the MOMENTUM 3 Trial Dr. Jonathan W. Haft, University of Michigan \| The Impact of Heartmate 3 Speed on Outcomes in the Momentum 3 Clinical Trial Dr. Jennifer Cowger, Henry Ford Hospital \| Variability in Blood Pressure Assessment in Patients Supported with the HeartMate 3 Dr. Ivan Netuka, Institute of Clinical and Experimental Medicine \| First Long-Term 5-years Experience with the HeartMate 3 LVAS in Multicentric Clinical Trial

About ISHLT

Governance

Membership & Networking

ISHLT2024

Meetings & Education

Research & Data

Publications & Resources

Organizational Remodel

How Do I